{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:00:35Z","timestamp":1788872435465,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MerckMillipore"},{"name":"Temptime"},{"name":"Bioengineering"},{"name":"GEA"},{"DOI":"10.13039\/100012884","name":"Bosch","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012884","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alfa Wassermann"},{"name":"OMPI (Stevanato Group)"},{"name":"Applikon"},{"name":"PALL"},{"name":"BD"},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1113282"],"award-info":[{"award-number":["OPP1113282"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2015.02.065","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T01:54:13Z","timestamp":1425434053000},"page":"2197-2202","source":"Crossref","is-referenced-by-count":6,"title":["Vaccines, our shared responsibility"],"prefix":"10.1016","volume":"33","author":[{"given":"Sonia","family":"Pagliusi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishabh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajinder Kumar","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2015.02.065_bib0090","article-title":"Applying an equity lens in the decade of vaccines","volume":"31","author":"Brearley","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.065_bib0095","unstructured":"WHO. Effective vaccine management assessments for 57 GAVI countries: average score of principal, sub-national, local district and service point level. Final Report for IRC Gavi, Available at: http:\/\/www.gavi.org\/Library\/GAVI...\/IRC...\/Final-Report-for-IRC-Nov-2014\/."},{"key":"10.1016\/j.vaccine.2015.02.065_bib0100","series-title":"Pandemic flu preparedness tools","year":"2012"},{"key":"10.1016\/j.vaccine.2015.02.065_bib0105","series-title":"Strategic multi-attribute ranking tool for vaccines","author":"Smart Vaccines","year":"2014"},{"key":"10.1016\/j.vaccine.2015.02.065_bib0110","series-title":"Ranking vaccines: a prioritization framework: Phase I: Demonstration of concept and a software blueprint","author":"Medicine","year":"2012"},{"key":"10.1016\/j.vaccine.2015.02.065_bib0115","series-title":"Ranking vaccines: a prioritization software tool: Phase II: Prototype of a decision-support system","author":"Medicine","year":"2013"},{"key":"10.1016\/j.vaccine.2015.02.065_bib0120","unstructured":"SMART Vaccines software available at: http:\/\/www.nap.edu\/smartvaccines."},{"issue":"7","key":"10.1016\/j.vaccine.2015.02.065_bib0125","doi-asserted-by":"crossref","first-page":"e11736","DOI":"10.1371\/journal.pone.0011736","article-title":"Modeling HIV vaccines in Brazil: assessing the impact of a future HIV vaccine on reducing new infections, mortality and number of people receiving ARV","volume":"5","author":"Fonseca","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.02.065_bib0130","series-title":"Polio eradication initiative: developing Sabin-inactivated polio vaccine (sIPV)","author":"World Health Organization","year":"2010"},{"issue":"12","key":"10.1016\/j.vaccine.2015.02.065_bib0135","doi-asserted-by":"crossref","first-page":"e83374","DOI":"10.1371\/journal.pone.0083374","article-title":"Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals","volume":"8","author":"Thommasen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.02.065_bib0140","unstructured":"Statement given by Dr.T.S. Rao. Biospectrum, February 2013. India set to get its indigenous rotavirus vaccine by 2014 \u2013 Biospectrum, New Delhi, India. Available at: http:\/\/www.biospectrumindia.com\/biospecindia\/news\/188605\/rotavirus-vaccine-positive-phase-iii-clinical-trial-results#sthash.ewDWsS0J.dpuf."},{"key":"10.1016\/j.vaccine.2015.02.065_bib0145","series-title":"Hand, foot, and mouth disease in China, 2008\u201312: an epidemiological study","author":"Liu","year":"2014"},{"key":"10.1016\/j.vaccine.2015.02.065_bib0150","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an Enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2015.02.065_bib0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjose","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.065_bib0160","series-title":"Assessing the programmatic suitability of vaccine candidates for WHO prequalification\u2014revision 2014","author":"WHO","year":"2014"},{"key":"10.1016\/j.vaccine.2015.02.065_bib0165","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1073\/pnas.1017334108","article-title":"Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques","volume":"108","author":"Lin","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2015.02.065_bib0170","doi-asserted-by":"crossref","first-page":"B81","DOI":"10.1016\/j.vaccine.2012.11.085","article-title":"Global support for new vaccine implementation in middle-income countries","volume":"31","author":"Kaddar","year":"2013","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T20:39:18Z","timestamp":1589488758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15002650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":17,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0264410X15002650"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}